AbbVie
ABBV
#26
Rank
C$463.52 B
Marketcap
$262.42
Share price
-0.08%
Change (1 day)
26.82%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of June 2024 : C$95.80 B

According to AbbVie's latest financial reports the company's total debt is C$95.80 B. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$78.76 B-8.26%
2022-12-31C$85.85 B-11.53%
2021-12-31C$97.05 B-11.56%
2020-12-31C$109.74 B26.86%
2019-12-31C$86.50 B57.31%
2018-12-31C$54.98 B17.05%
2017-12-31C$46.98 B-5.11%
2016-12-31C$49.51 B12.57%
2015-12-31C$43.98 B153.19%
2014-12-31C$17.37 B10.9%
2013-12-31C$15.66 B0.28%
2012-12-31C$15.61 B31890.39%
2011-12-31C$48.82 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
C$93.15 B-2.77%๐Ÿ‡บ๐Ÿ‡ธ USA
C$73.25 B-23.54%๐Ÿ‡บ๐Ÿ‡ธ USA
C$39.18 B-59.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$84.97 B-11.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$31.67 B-66.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.03 B-90.57%๐Ÿ‡บ๐Ÿ‡ธ USA
C$29.07 B-69.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$45.48 B-52.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$0.34 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA